Aptamer Market opportunities driven by research advancements, clinical adoption, and technological innovation
The Aptamer Market is experiencing significant growth, driven by ongoing research advancements, increasing clinical adoption, and technological innovation across diagnostics, therapeutics, and biotechnology. Aptamers, short DNA or RNA sequences, bind specifically to target molecules, providing a versatile and reliable alternative to antibodies. Their high specificity, stability, and...
0 Commenti
0 condivisioni
133 Views
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Русский
Română
Português
Ελληνικά
Tiếng Việt